CN105943644A - Traditional Chinese medicine moxibustion composition for lumbar muscle degeneration and preparation method and application of traditional Chinese medicine moxibustion composition - Google Patents
Traditional Chinese medicine moxibustion composition for lumbar muscle degeneration and preparation method and application of traditional Chinese medicine moxibustion composition Download PDFInfo
- Publication number
- CN105943644A CN105943644A CN201610494727.9A CN201610494727A CN105943644A CN 105943644 A CN105943644 A CN 105943644A CN 201610494727 A CN201610494727 A CN 201610494727A CN 105943644 A CN105943644 A CN 105943644A
- Authority
- CN
- China
- Prior art keywords
- parts
- moxibustion
- chinese medicine
- traditional chinese
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
Abstract
The invention relates to a traditional Chinese medicine moxibustion composition for lumbar muscle degeneration and a preparation method and application of the traditional Chinese medicine moxibustion composition. The traditional Chinese medicine moxibustion composition is prepared from the following pharmaceutical raw materials: 40-60 parts of kadsura pepper stem, 30-50 parts of radix clematidis, 35-55 parts of rhizoma cibotii, 40-60 parts of fructus psoraleae, 50-70 parts of garden balsam stem, 30-50 parts of lycopodium clavatum, 25-45 parts of ligusticum clavatum, 50-70 parts of ramulus mori, 40-60 parts of radix achyranthis bidentatae and 1-3 parts of borneol. The traditional Chinese medicine moxibustion composition is smartly integrated with the advantages of moxibustion with salt and moxibustion with a moxa box, the respective advantages of the two moxibustion methods are maintained, a traditional Chinese medicine formula is also added, the functions of moxibustion with salt, moxibustion with medicine and moxibustion with the moxa box are combined into one body to take curative effect. Meanwhile, the disadvantages existing in moxibustion with salt and moxibustion with the moxa box are also avoided. The traditional Chinese medicine moxibustion composition is simple and convenient in material taking, easy to learn and use, and reliable in curative effect, pain of numerous patients is relieved, the moxibustion with salt improves the permeation for slow conduction of moxibustion, the therapeutic effect of medicine is exerted, the moxibustion time is prolonged, and the appearance of scalding in the moxibustion process is effectively avoided.
Description
Technical field
The present invention relates to medical treatment and health care technology field, specifically, be a kind of Chinese medicine moxibustion compositions for lumbar muscle strain and its preparation method and application.
Background technology
" moxa-moxibustion " refers to Folium Artemisiae Argyi is that master on body surface point or press, fire-cure to prevent and cure diseases and a kind of external treatment with Chinese medicine method of health body-building by affected part temperature, is the important branch of Chinese medicine.Moxibustion therapy has the effect of promoting the flow of QI-blood by warming the meridian, dispelling cold and removing dampness, blood circulation promoting and blood stasis dispelling, warmly nourishing Yangqi and health care.The clinical practice of thousands of years proves the remarkable result of moxa-moxibustion again and again.Nowadays, moxibustion therapy is still widely used in clinic, is also releasing slight illness for extensive patients, is being the most outstanding a kind of external treatment of Chinese medicine.
The classification of moxibustion therapy is a lot, and in moxa-moxibustion, sandwiched moxibustion and moxa-moxibustion box moxibustion are to apply the most universal moxibustion method at present.Sandwiched moxibustion head sees Ge Hong handbook of Prescription for Emergency, is divided into every Rhizoma Zingiberis Recens moxibustion, and every monkshood cake moxibustion, garlic moxibustion, every salt moxibustion etc..Refer to fill and lead up omphalos with the Sal of clean dry every salt moxibustion, the method above putting big moxa cone moxibustion, there is recuperating depleted YANG and rescuing the patient from collapse, warming spleen and stomach for dispelling cold, the effect of the warm part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, be for general on the moxibustion of umbilicus position.Moxa-moxibustion box moxibustion is that moxa roll one end that 4-5 cuts about 5cm length is lighted, and the most endways puts moxibustion box into, improves oxygen supply by adjusting the aperture of lid and box body both sides, thus controls the moxibustion temperature of moxibustion box；Moxa-moxibustion box moxibustion can be widely applied to the flat parts such as shoulder back of the body waist abdomen, is particularly well-suited to sympotoms caused by cold factors, deficient syndrome, stasis of blood disease.
Though it is good every salt moxibustion effect, but it is limited only to umbilicus position, and moxibustion is to coda, Sal easily bursts and scalds patient, and Sal is filled into umbilicus, the component of general patient salt amount and Folium Artemisiae Argyi is all difficult to hold, as boiling hot in felt, often cannot process, cause umbilicus to scald, disease does not obtains medical treatment, and loses confidence to every salt moxibustion even moxa-moxibustion on the contrary；Operation is very easy by contrast in moxibustion box moxibustion, also safety is compared, but there is also the problem that moxibustion amount is difficult to hold, if moxibustion amount is excessive, then patient feels bright boiling hot, needs to raise moxibustion box or place mat gauze comes heat insulation, often cause moxibustion heat uneven, thus affect therapeutic effect, the most easily cause scald to scald bubble.
Chinese patent 2009102314905 discloses the skin surface infiltration Chinese medicinal preparation of a kind of acupuncture, including following components: Folium Artemisiae Argyi, Rhizoma Corydalis, Flos Carthami, Radix Notoginseng, Rhizoma Chuanxiong, Caulis Spatholobi, Borneolum Syntheticum, Radix Angelicae Sinensis, Rhizoma Zingiberis Recens and Rhizoma Cyperi；When treatment face, all diseases of having a headache add Herba Asari, Rhizoma Et Radix Notopterygii, Fructus Ligustri Lucidi, Semen Cassiae and Flos Chrysanthemi in described Chinese medicine preparation component；Radix Ophiopogonis, Herba Agrimoniae, Galla Chinensis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis and Radix Cynanchi Paniculati is added during the treatment all diseases of thorax abdomen；The Radix Paeoniae Alba, Herba Leonuri, Flos Campsis, Olibanum and Myrrha is added during the treatment all diseases of gynecological；Radix Salviae Miltiorrhizae, Herba speranskiae tuberculatae, Herba Lycopodii, Radix Clematidis, Caulis Trachelospermi, Pheretima and Rhizoma Drynariae is added during treatment extremity, all diseases in joint；This Chinese medicine preparation energy blood circulation promoting and blood stasis dispelling, vigorate qi and replenish the blood, and economical and practical, manufacture method is simple, can obtain good economic benefits.Chinese patent 2007100848311 discloses the moxibustion medicine of a kind for the treatment of pain of lumbus, leg, neck and shoulder, this medicine is made up of following component, Semen Impatientis, Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma Arisaematis, Rhizoma Pinelliae, Herba Asari, Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani), Pericarpium Zanthoxyli, Radix Cynanchi Paniculati, the Radix Angelicae Dahuricae, Galla Chinensis, Radix Zanthoxyli, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Semen Persicae, Flos Carthami, Radix Clematidis, the Radix Paeoniae Alba, Radix Gentianae Macrophyllae, Rhizoma Cyperi, the each equal portions of Radix Tripterygii Wilfordii, add the Mentholum of said medicine gross weight 10%, the Borneolum Syntheticum of 10%, the Semen Sinapis of 0.5%, pulverizing is 200 mesh fine powders, package, this drug regimen treating pain of lumbus, leg, neck and shoulder is sick, evident in efficacy, and the course for the treatment of is shorter, instant effect.Prior art is mainly by making Chinese medicine preparation or medicinal powder package or simple every salt moxibustion or moxibustion box moxibustion；And by being difficult to hold moxibustion amount every salt moxibustion or moxibustion box moxibustion, moxibustion effect is limited.Therefore for the shortcoming of prior art, it is necessary to research and develop a kind of collection every the medicine salt moxibustion acting on one of salt moxibustion, herbs-partition moxibustion and moxibustion box moxibustion and Chinese medicine composition, and about this technical scheme, yet there are no report.
Summary of the invention
" medicine salt moxibustion " is that the one of moxa-moxibustion, Halitum and Chinese medicine three's perfect adaptation is combined moxibustion therapy.Belong to the pioneering application of the present invention.Halitum, salty in the mouth, enter kidney, have the merit of diathermanous the kidney invigorating, dispelling cold and dehumidification.The Chinese medicine moxibustion compositions of the present invention acts on lumbosacral governor vessel and both sides bladder warp, takes the big caves of health care such as shen shu, the gate of vitality, yao yang kuan, has the effect of element culturing fixed folder, kidney tonifying marrow facilitating, relaxing muscles and tendons and activating QI and blood in the collateral.Governor vessel leads to spinal cord, and spinal nerves distribution is respectively provided with each internal organs internal and is closely connected, and the back shu points of governor vessel both sides is also relevant to the vital organs of the human body, can nurse one's health whole body internal organs function by conditioning governor vessel and bladder warp.Be applicable to low back muscle strain, meridian qi and blood blocks the obstructed and overall conditioning of whole body.
It is an object of the invention to for deficiency of the prior art, it is provided that a kind of Chinese medicine composition for traditional Chinese medical science moxibustion.
Another purpose of the present invention is to provide a kind of Chinese medicines salt for medicine salt moxibustion.
Another the purpose of the present invention is to provide Chinese medicine composition as above, the application in the medicine of lumbar muscle strain, dysmenorrhea, menoxenia, pelvic inflammatory disease is treated in preparation of the Chinese medicines salt.
For achieving the above object, the present invention adopts the technical scheme that:
A kind of Chinese medicine composition for traditional Chinese medical science moxibustion, described Chinese medicine composition is made up of the crude drug of following weight portion: Caulis Piperis Kadsurae 40-60 part, Radix Clematidis 30-50 part, Rhizoma Cibotii 35-55 part, Fructus Psoraleae 40-60 part, Herba speranskiae tuberculatae 50-70 part, Herba Lycopodii 30-50 part, Rhizoma Chuanxiong 25-45 part, Ramulus Mori 50-70 part, Radix Achyranthis Bidentatae 40-60 part, Borneolum Syntheticum 1-3 part.
Preferably, described Chinese medicine composition is made up of the crude drug of following weight portion: Caulis Piperis Kadsurae 45-55 part, Radix Clematidis 35-45 part, Rhizoma Cibotii 40-50 part, Fructus Psoraleae 45-55 part, Herba speranskiae tuberculatae 55-65 part, Herba Lycopodii 35-45 part, Rhizoma Chuanxiong 30-40 part, Ramulus Mori 55-65 part, Radix Achyranthis Bidentatae 45-55 part, Borneolum Syntheticum 1-2 part.
Preferably, described Chinese medicine composition is made up of the crude drug of following weight portion: Caulis Piperis Kadsurae 50 parts, Radix Clematidis 40 parts, Rhizoma Cibotii 45 parts, Fructus Psoraleae 50 parts, Herba speranskiae tuberculatae 60 parts, Herba Lycopodii 40 parts, Rhizoma Chuanxiong 35 parts, Ramulus Mori 60 parts, Radix Achyranthis Bidentatae 50 parts, Borneolum Syntheticum 2 parts.
For realizing above-mentioned second purpose, the present invention adopts the technical scheme that:
A kind of Chinese medicines salt for medicine salt moxibustion, described Chinese medicines salt includes sea salt and the Chinese medicine composition of arbitrary described weight portion.
Preferably, the weight portion of described sea salt is 700-900 part.
For realizing above-mentioned 3rd purpose, the present invention adopts the technical scheme that:
Arbitrary described Chinese medicine composition, the application in the medicine of lumbar muscle strain, dysmenorrhea, menoxenia, pelvic inflammatory disease is treated in preparation of the Chinese medicines salt.
The preparation method of described medicine is as follows:
(1) raw material is weighed according to proportioning；
(2) Chinese medicine composition is pulverized, cross 100 mesh sieves, obtain medicated powder；
(3) take sea salt slow fire parch, during light yellow complexion, add the medicated powder of step 2 preparation, parch together.
The invention has the advantages that:
1, the present invention has played moxa-moxibustion and Chinese medicine double treatment effect, substantially increases curative effect.
2, the present invention is easy to use, it is easy to operation, can use in the family, is not limited to doctor and medical space, and price is far below General Clinical diagnosis and treatment price simultaneously, it is easy to universal.
3, the present invention is ingenious incorporates every salt moxibustion and the advantage of moxibustion box moxibustion, has both remained two kinds of respective advantages of moxibustion therapy, adds again prescription, collects and acts on one, three-in-one performance curative effect every salt moxibustion, herbs-partition moxibustion and moxibustion box moxibustion；Simultaneously, it is to avoid every the drawback that salt moxibustion and moxibustion box moxibustion exist.
4, the medicine salt moxibustion of the present invention is drawn materials simplicity, is easy to learn and use, and curative effect is reliable, releasing misery for numerous patients, medicine salt moxibustion not only increases the osmosis of moxa-moxibustion conduction slowly, has played the therapeutical effect of medicine, extend moxibustion time, and during effectively prevent moxa-moxibustion, scald the generation of bubble.
5, the Chinese medicine composition of the present invention for lumbar muscle strain, dysmenorrhea, menoxenia, pelvic inflammatory disease effect notable.
Accompanying drawing explanation
Attached Figure 1It it is the material object of Chinese medicine moxibustion compositions of the present inventionFigure。
Detailed description of the invention
Below in conjunction with detailed description of the invention, the present invention is expanded on further.Should be understood that these embodiments are merely to illustrate the present invention rather than limit the scope of the present invention.In addition, it is to be understood that after having read the content that the present invention records, the present invention can be made various changes or modifications by those skilled in the art, and these equivalent form of values fall within appended by the application equallyClaimBook limited range.
Embodiment 1 is for the Chinese medicine composition () of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 50 parts, Radix Clematidis 40 parts, Rhizoma Cibotii 45 parts, Fructus Psoraleae 50 parts, Herba speranskiae tuberculatae 60 parts, Herba Lycopodii 40 parts, Rhizoma Chuanxiong 35 parts, Ramulus Mori 60 parts, Radix Achyranthis Bidentatae 50 parts, Borneolum Syntheticum 2 parts.
Embodiment 2 is for the Chinese medicine composition (two) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 40 parts, Radix Clematidis 30 parts, Rhizoma Cibotii 35 parts, Fructus Psoraleae 40 parts, Herba speranskiae tuberculatae 50 parts, Herba Lycopodii 30 parts, Rhizoma Chuanxiong 25 parts, Ramulus Mori 50 parts, Radix Achyranthis Bidentatae 40 parts, Borneolum Syntheticum 1 part.
Embodiment 3 is for the Chinese medicine composition (three) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 30 parts, Rhizoma Cibotii 35 parts, Fructus Psoraleae 40 parts, Herba speranskiae tuberculatae 50 parts, Herba Lycopodii 30 parts, Rhizoma Chuanxiong 25 parts, Ramulus Mori 50 parts, Radix Achyranthis Bidentatae 40 parts, Borneolum Syntheticum 1 part.
Embodiment 4 is for the Chinese medicine composition (four) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 35 parts, Fructus Psoraleae 40 parts, Herba speranskiae tuberculatae 50 parts, Herba Lycopodii 30 parts, Rhizoma Chuanxiong 25 parts, Ramulus Mori 50 parts, Radix Achyranthis Bidentatae 40 parts, Borneolum Syntheticum 1 part.
Embodiment 5 is for the Chinese medicine composition (five) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 55 parts, Fructus Psoraleae 40 parts, Herba speranskiae tuberculatae 50 parts, Herba Lycopodii 30 parts, Rhizoma Chuanxiong 25 parts, Ramulus Mori 50 parts, Radix Achyranthis Bidentatae 40 parts, Borneolum Syntheticum 1 part.
Embodiment 6 is for the Chinese medicine composition (six) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 55 parts, Fructus Psoraleae 60 parts, Herba speranskiae tuberculatae 50 parts, Herba Lycopodii 30 parts, Rhizoma Chuanxiong 25 parts, Ramulus Mori 50 parts, Radix Achyranthis Bidentatae 40 parts, Borneolum Syntheticum 1 part.
Embodiment 7 is for the Chinese medicine composition (seven) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 55 parts, Fructus Psoraleae 60 parts, Herba speranskiae tuberculatae 70 parts, Herba Lycopodii 30 parts, Rhizoma Chuanxiong 25 parts, Ramulus Mori 50 parts, Radix Achyranthis Bidentatae 40 parts, Borneolum Syntheticum 1 part.
Embodiment 8 is for the Chinese medicine composition (eight) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 55 parts, Fructus Psoraleae 60 parts, Herba speranskiae tuberculatae 70 parts, Herba Lycopodii 50 parts, Rhizoma Chuanxiong 25 parts, Ramulus Mori 50 parts, Radix Achyranthis Bidentatae 40 parts, Borneolum Syntheticum 1 part.
Embodiment 9 is for the Chinese medicine composition (nine) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 55 parts, Fructus Psoraleae 60 parts, Herba speranskiae tuberculatae 70 parts, Herba Lycopodii 50 parts, Rhizoma Chuanxiong 45 parts, Ramulus Mori 50 parts, Radix Achyranthis Bidentatae 40 parts, Borneolum Syntheticum 1 part.
Embodiment 10 is for the Chinese medicine composition (ten) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 55 parts, Fructus Psoraleae 60 parts, Herba speranskiae tuberculatae 70 parts, Herba Lycopodii 50 parts, Rhizoma Chuanxiong 45 parts, Ramulus Mori 70 parts, Radix Achyranthis Bidentatae 40 parts, Borneolum Syntheticum 1 part.
Embodiment 11 is for the Chinese medicine composition (11) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 55 parts, Fructus Psoraleae 60 parts, Herba speranskiae tuberculatae 70 parts, Herba Lycopodii 50 parts, Rhizoma Chuanxiong 45 parts, Ramulus Mori 70 parts, Radix Achyranthis Bidentatae 60 parts, Borneolum Syntheticum 1 part.
Embodiment 12 is for the Chinese medicine composition (12) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 55 parts, Fructus Psoraleae 60 parts, Herba speranskiae tuberculatae 70 parts, Herba Lycopodii 50 parts, Rhizoma Chuanxiong 45 parts, Ramulus Mori 70 parts, Radix Achyranthis Bidentatae 60 parts, Borneolum Syntheticum 3 parts.
Embodiment 13 is for the Chinese medicine composition (13) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 55 parts, Radix Clematidis 45 parts, Rhizoma Cibotii 50 parts, Fructus Psoraleae 55 parts, Herba speranskiae tuberculatae 65 parts, Herba Lycopodii 45 parts, Rhizoma Chuanxiong 40 parts, Ramulus Mori 65 parts, Radix Achyranthis Bidentatae 55 parts, Borneolum Syntheticum 2 parts.
Embodiment 14 is for the Chinese medicine composition (14) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 45 parts, Radix Clematidis 35 parts, Rhizoma Cibotii 40 parts, Fructus Psoraleae 45 parts, Herba speranskiae tuberculatae 55 parts, Herba Lycopodii 35 parts, Rhizoma Chuanxiong 30 parts, Ramulus Mori 55 parts, Radix Achyranthis Bidentatae 45 parts, Borneolum Syntheticum 1 part.
Embodiment 15 is for the Chinese medicine composition (15) of traditional Chinese medical science moxibustion
Caulis Piperis Kadsurae 45 parts, Radix Clematidis 35 parts, Rhizoma Cibotii 40 parts, Fructus Psoraleae 45 parts, Herba speranskiae tuberculatae 55 parts, Herba Lycopodii 45 parts, Rhizoma Chuanxiong 40 parts, Ramulus Mori 65 parts, Radix Achyranthis Bidentatae 55 parts, Borneolum Syntheticum 2 parts.
Embodiment 16 is for the Chinese medicine composition (16) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 45 parts, 40 parts of Flos Carthami, Radix Salviae Miltiorrhizae 50 parts, the Radix Aucklandiae 25 parts, Rhizoma Cyperi 40 parts, Herba Leonuri 80 parts, Rhizoma Chuanxiong 35 parts, Borneolum Syntheticum 2.
Embodiment 17 is for the Chinese medicine composition (17) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 35 parts, 30 parts of Flos Carthami, Radix Salviae Miltiorrhizae 40 parts, the Radix Aucklandiae 15 parts, Rhizoma Cyperi 30 parts, Herba Leonuri 70 parts, Rhizoma Chuanxiong 25 parts, Borneolum Syntheticum 1.
Embodiment 18 is for the Chinese medicine composition (18) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 55 parts, 30 parts of Flos Carthami, Radix Salviae Miltiorrhizae 40 parts, the Radix Aucklandiae 15 parts, Rhizoma Cyperi 30 parts, Herba Leonuri 70 parts, Rhizoma Chuanxiong 25 parts, Borneolum Syntheticum 1.
Embodiment 19 is for the Chinese medicine composition (19) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 55 parts, 50 parts of Flos Carthami, Radix Salviae Miltiorrhizae 40 parts, the Radix Aucklandiae 15 parts, Rhizoma Cyperi 30 parts, Herba Leonuri 70 parts, Rhizoma Chuanxiong 25 parts, Borneolum Syntheticum 1.
Embodiment 20 is for the Chinese medicine composition (20) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 55 parts, 50 parts of Flos Carthami, Radix Salviae Miltiorrhizae 60 parts, the Radix Aucklandiae 15 parts, Rhizoma Cyperi 30 parts, Herba Leonuri 70 parts, Rhizoma Chuanxiong 25 parts, Borneolum Syntheticum 1.
Embodiment 21 is for the Chinese medicine composition (21) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 55 parts, 50 parts of Flos Carthami, Radix Salviae Miltiorrhizae 60 parts, the Radix Aucklandiae 35 parts, Rhizoma Cyperi 30 parts, Herba Leonuri 70 parts, Rhizoma Chuanxiong 25 parts, Borneolum Syntheticum 1.
Embodiment 22 is for the Chinese medicine composition (22) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 55 parts, 50 parts of Flos Carthami, Radix Salviae Miltiorrhizae 60 parts, the Radix Aucklandiae 35 parts, Rhizoma Cyperi 50 parts, Herba Leonuri 70 parts, Rhizoma Chuanxiong 25 parts, Borneolum Syntheticum 1.
Embodiment 23 is for the Chinese medicine composition (23) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 55 parts, 50 parts of Flos Carthami, Radix Salviae Miltiorrhizae 60 parts, the Radix Aucklandiae 35 parts, Rhizoma Cyperi 50 parts, Herba Leonuri 90 parts, Rhizoma Chuanxiong 25 parts, Borneolum Syntheticum 1.
Embodiment 24 is for the Chinese medicine composition (24) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 55 parts, 50 parts of Flos Carthami, Radix Salviae Miltiorrhizae 60 parts, the Radix Aucklandiae 35 parts, Rhizoma Cyperi 50 parts, Herba Leonuri 90 parts, Rhizoma Chuanxiong 45 parts, Borneolum Syntheticum 1.
Embodiment 25 is for the Chinese medicine composition (25) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 55 parts, 50 parts of Flos Carthami, Radix Salviae Miltiorrhizae 60 parts, the Radix Aucklandiae 35 parts, Rhizoma Cyperi 50 parts, Herba Leonuri 90 parts, Rhizoma Chuanxiong 45 parts, Borneolum Syntheticum 3.
Embodiment 26 is for the Chinese medicine composition (26) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 40 parts, 35 parts of Flos Carthami, Radix Salviae Miltiorrhizae 45 parts, the Radix Aucklandiae 20 parts, Rhizoma Cyperi 35 parts, Herba Leonuri 75 parts, Rhizoma Chuanxiong 30 parts, Borneolum Syntheticum 1.
Embodiment 27 is for the Chinese medicine composition (27) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 50 parts, 45 parts of Flos Carthami, Radix Salviae Miltiorrhizae 55 parts, the Radix Aucklandiae 30 parts, Rhizoma Cyperi 45 parts, Herba Leonuri 85 parts, Rhizoma Chuanxiong 40 parts, Borneolum Syntheticum 2.
Embodiment 28 is for the Chinese medicine composition (28) of traditional Chinese medical science moxibustion
Radix Angelicae Sinensis 40 parts, 35 parts of Flos Carthami, Radix Salviae Miltiorrhizae 45 parts, the Radix Aucklandiae 20 parts, Rhizoma Cyperi 45 parts, Herba Leonuri 85 parts, Rhizoma Chuanxiong 40 parts, Borneolum Syntheticum 2.
Embodiment 29 is for the Chinese medicines salt of medicine salt moxibustion
The arbitrary described Chinese medicine composition of Example 1-28, adds the sea salt of 700-900 part.
Embodiment 30 is for the preparation method of the Chinese medicine composition of traditional Chinese medical science moxibustion
(1) weigh raw material of Chinese medicine by the arbitrary described weight portion of embodiment 1-28, take 700-900 part sea salt；
(2) important composition is pulverized, cross 60-200 mesh sieve, obtain Chinese medicinal powder；
(3) by sea salt slow fire parch, add the medicated powder of step 2 preparation, parch together, pack during light yellow complexion, obtain Chinese medicines salt.
Embodiment 31 moxibustion method
The medicine salt prepared is dried in the air cool standby, takes 100 grams of medicine salt and put into spun yarn cloth bag,Such as figure 1Shown in.During moxibustion, medicine salt in gauze bag is spread out and is flat on moxibustion cassette bottom portion skin.4-5 cuts moxa roll light and put moxibustion box into, moxibustion box is placed on moxibustion on medicine salt bag.During moxa-moxibustion, moxibustion heat can penetrate progressively through medicine salt entrance cave district slowly and persistently play a role, the warm infiltration of patient's persistence of sensation.
The Chinese medicine moxibustion compositions (i.e. the Chinese medicine composition of embodiment 1-15) of the present invention acts on lumbosacral governor vessel and both sides bladder warp, takes the big caves of health care such as shen shu, the gate of vitality, yao yang kuan, has the effect of element culturing fixed folder, kidney tonifying marrow facilitating, relaxing muscles and tendons and activating QI and blood in the collateral.Governor vessel leads to spinal cord, and spinal nerves distribution is respectively provided with each internal organs internal and is closely connected, and the back shu points of governor vessel both sides is also relevant to the vital organs of the human body, can nurse one's health whole body internal organs function by conditioning governor vessel and bladder warp.Be applicable to low back muscle strain, meridian qi and blood blocks the obstructed and overall conditioning of whole body.
Embodiment 32 present invention is for the clinical experiment of the traditional Chinese medicine composition for treating lumbar muscle strain of traditional Chinese medical science moxibustion
1 clinical data
1.1 physical data
Object of study selects 120 example lumbar muscle strain patients of hospital outpatient.Wherein women 55 example, male 65 example.Age of onset 25-51 year, 32 years old mean age, the course of disease 2 months-2 years, average 6 months.Patient is randomly divided into four groups, and often group patient cases's physical data no significant difference, has comparability (P > 0.05).
1.2 diagnostic criteria
ReferenceCountryThe diagnostic criteria of lumbar muscle strain in " Chinese medical disease Standardization of diagnosis and curative effect " that the State Administration of Traditional Chinese Medicines promulgates.Clinical symptoms: flank pain, alleviates during rest, increases the weight of time tired, suitably alleviate when activity or frequent change position, increase the weight of when activity is exaggerated, weight when not yet get up in the morning, getting up and alleviate after light activity, the pain increased the most for a long time in work of bending over, and sometimes hits waist with fist and can make pain relief.Sign: waist can have extensive tenderness, is positioned on musculus sacrospinalis position, spinous process both sides, crista iliaca rear portion or posterior surface of scral bone low back muscle at point more, and touch chronognosis psoas muscle is elastic poor or occurs that psoas muscle is stiff nonelastic, and there is streak change local；Or psoas muscle withers soft, in thin-cord type, tenderness is the most acute, and waist range of activity is without obvious obstacle.Check: how without exception x ray examination is, and minority can have hyperosteogeny or deformity of spine.
1.3 case inclusive criterias
Meet above-mentioned lumbar muscle strain diagnostic criteria, belong to tcm syndrome classification kidney deficiency blood stasis type person, this Therapeutic Method of voluntary participation, during treatment, disable other treatment method.
1.4 exclusion standard
(1) patients with lumbar disc herniation is got rid of；(2) lumbar vertebra other diseases is got rid of, such as Spinal Diseases, spinal stenosis and sacroiliac joint and buttocks disease etc.；(3) eliminating is associated with the bone destruction person such as bone tuberculosis, bone tumor；(4) trimester of pregnancy or women breast-feeding their children are got rid of；(5) severe primary disease and psychotics such as merging cardiovascular and cerebrovascular vessel, liver, kidney, hemopoietic system, hormonal system are got rid of.
2 research methoies
2.1 Therapeutic Method
Treatment group: the method with reference to embodiment 1 and embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31, once a day.Each 30 minutes.10 1 course for the treatment of, totally 30 courses for the treatment of.
Compare one group: Chinese medicine composition is as follows: Caulis Piperis Kadsurae 50 parts, Radix Clematidis 40 parts, Rhizoma Cibotii 45 parts, Fructus Psoraleae 50 parts, Herba speranskiae tuberculatae 60 parts, Herba Lycopodii 40 parts, Rhizoma Chuanxiong 35 parts, Ramulus Mori 60 parts, Radix Achyranthis Bidentatae 50 parts, Borneolum Syntheticum 2 parts.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31, once a day.Each 30 minutes.10 1 course for the treatment of, totally 30 courses for the treatment of.
Compare two groups: Chinese medicine composition is as follows: Radix Clematidis 40 parts, Rhizoma Cibotii 45 parts, Fructus Psoraleae 50 parts, Herba speranskiae tuberculatae 60 parts, Herba Lycopodii 40 parts, Rhizoma Chuanxiong 35 parts, Radix Achyranthis Bidentatae 50 parts, Borneolum Syntheticum 2 parts.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31, once a day.Each 30 minutes.10 1 course for the treatment of, totally 30 courses for the treatment of.
Compare three groups: Chinese medicine composition is as follows: Caulis Piperis Kadsurae 20 parts, Radix Clematidis 20 parts, Rhizoma Cibotii 20 parts, Fructus Psoraleae 20 parts, Herba speranskiae tuberculatae 80 parts, Herba Lycopodii 80 parts, Rhizoma Chuanxiong 70 parts, Ramulus Mori 80 parts, Radix Achyranthis Bidentatae 80 parts, Borneolum Syntheticum 2 parts.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31, once a day.Each 30 minutes.10 1 course for the treatment of, totally 30 courses for the treatment of.
2.2 criterion of therapeutical effect
ReferenceCountry" the disease of tcm Standardization of diagnosis and curative effect " that the State Administration of Traditional Chinese Medicines promulgates.
Curing: pain disappears with tenderness, functional rehabilitation can be worked and work；Effective: pain substantially alleviates with tenderness, simultaneous phenomenon improves earlier above, and function is recovered substantially, can work and work；Invalid: sings and symptoms is unchanged.Effective percentage=(curing number+effective number)/total number of persons.
3 therapeutic outcomes
Result of the test is such asFollowing table。
Table 1Four groups of patient clinical comparitive study after treatment
| Group | Number of cases | Cure (%) | Effective (%) | Invalid (%) | Total effective rate (%) |
| Treatment group | 36 | 21(58.3) | 11(30.6) | 4(11.1) | 32(88.9) |
| Compare one group | 28 | 7(25.0)* | 9(32.1) | 12(42.9) | 16(57.1)* |
| Compare two groups | 28 | 8(28.6)* | 11(39.3) | 9(32.1) | 19(67.9)* |
| Compare three groups | 28 | 7(25.0)* | 17(60.7) | 4(14.3) | 24(85.7) |
Note: * represents and compares with treatment group, P < 0.05.
Through the treatment of three courses for the treatment of and follow up a case by regular visits to, result display treatment group cures 21 people, effective 11 people, invalid 4 people, total effective rate 88.9%.Treatment group with compare one group, compare two groups and compare, treatment group total effective rate and cure rate are all significantly better than comparison one group and comparison two groups, and P < 0.05, difference has statistical significance.Treatment group compares with compareing three groups, and treatment group cure rate is significantly better than comparison three groups, and P < 0.05, difference has statistical significance.The above results shows that treatment group curative effect is better than matched group.
Obvious adverse events is all there is not during above-mentioned four groups of patient treatments.Obvious hepatic and renal function injure, serious disease in the blood system and cardiovascular and cerebrovascular vessel thunder bolt all do not occur.Illustrate the treatment of Chinese medicine composition of the present invention to patient without obvious harmful effect.
Embodiment 33 present invention is for the clinical experiment of the traditional Chinese medicine composition for treating dysmenorrhea of traditional Chinese medical science moxibustion
1 clinical data
1.1 physical data
Object of study selects the dysmenorrhea patient that clarifies a diagnosis of 100 examples of hospital outpatient, is randomly divided into 4 groups, treatment group 31 example, age 17-27 year, average 20.6 years old, the course of disease 4 months to 5 years, average 3.18 years；Compare one group of 23 example, age 17-31 year, average 23.3 years old, the course of disease 4 months to 6 years, average 3.31 years；Compare two group of 23 example, age 16-27 year, average 19.5 years old, the course of disease 3 months to 4 years, average 3.51 years；Compare three group of 23 example, age 18-29 year, average 19.8 years old, the course of disease 4 months to 4 years, average 3.11 years.Four groups of patient's physical data (including age, the course of disease, the state of an illness), through statistical analysis, no significant difference (P > 0.05), have comparability.
1.2 diagnostic criteria
With reference to new Chinese medicine guideline of clinical investigations
(1) tcm diagnosis standard: women is all in menstrual period or (more than 1 week) occurs that periodically hypogastralgia is primary symptom through front and back, uncomfortable with other, so that impact life and worker.Chinese medical discrimination belongs to syndrome of blood stasis, premenstruum lower abdominal distention pain, delayed menstrual cycle amount is few, and menses are dark, and tongue fur is white or dark violet, stringy and thready pulse or heavy tight；
(2) Western medicine diagnose standard: through gynecologial examination, genitals without significant organic pathological changes, is mainly in the maiden of 2～3 years after menarche, or the young woman do not given birth to；
1.3 case inclusive criterias
Age 17-30 year unmarried female, meet the diagnostic criteria of doctor trained in Western medicine primary dysmenorrhea, meet the diagnostic criteria of traditional Chinese medical science dysmenorrhea, menstrual cycle, at (28 ± 7) d, accepts treatment voluntarily, observe.
1.4 exclusion standard
Through B ultrasonic and gynecologial examination, it was demonstrated that the secondary dysmenorrhea caused due to the diseases such as endometriosis, pelvic inflammatory disease, adenomyosis or other factors；The irregular person of menstrual cycle；Accept other relevant treatment, the effect index observer of this research may have been affected；It is associated with the serious life-threatening primary diseases such as cardiovascular and cerebrovascular vessel, liver, kidney and hemopoietic system, and psychotic etc..
2 research methoies
2.1 Therapeutic Method
Treatment group: the method with reference to embodiment 16 and embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31, starts treatment for first 7 days in menstrual onset, and every day 2 times, 10 days is a course for the treatment of, treats 2 menstrual cycle.
Compare one group: Chinese medicine composition is as follows: Radix Angelicae Sinensis 45 parts, 40 parts of Flos Carthami, Radix Salviae Miltiorrhizae 50 parts, the Radix Aucklandiae 25 parts, Herba Leonuri 80 parts, Rhizoma Chuanxiong 35 parts, Borneolum Syntheticum 2.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Menstrual onset starts treatment for first 7 days, and every day 2 times, 10 days is a course for the treatment of, treats 2 menstrual cycle.
Compare two groups: Chinese medicine composition is as follows: Radix Angelicae Sinensis 45 parts, 40 parts of Flos Carthami, Radix Salviae Miltiorrhizae 50 parts, the Radix Aucklandiae 25 parts, Rhizoma Cyperi 40 parts, Rhizoma Chuanxiong 35 parts, Borneolum Syntheticum 2.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Menstrual onset starts treatment for first 7 days, and every day 2 times, 10 days is a course for the treatment of, treats 2 menstrual cycle.
Compare three groups: Chinese medicine composition is as follows: Radix Angelicae Sinensis 20 parts, 70 parts of Flos Carthami, Radix Salviae Miltiorrhizae 70 parts, the Radix Aucklandiae 60 parts, Rhizoma Cyperi 70 parts, Herba Leonuri 50 parts, Rhizoma Chuanxiong 70 parts, Borneolum Syntheticum 2.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Menstrual onset starts treatment for first 7 days, and every day 2 times, 10 days is a course for the treatment of, treats 2 menstrual cycle.
2.2 symptom integral standards
Symptom integral standard: menstrual period and front and back lower abdomen pain 5 points (basis point), stomachache 1 point unbearably, suffer from abdominal pain obvious 0.5 point, dripping cold sweat 1 point, extreme cold of the limbs 1 point, feel restless 1 point, suffer a shock 1 point, pale complexion, 1 point need to be lain up, affect work and study 1 point, with general pain relieving measure not alleviation person 1 point, with general pain relieving measure alleviation person 0.5 point, companion's waist aches 0.5 point, companion's nausea and vomiting 0.5 point, accompanies rectal tenesmus 0.5 point, the pain 0.5 point (often increase and add 0.5 point in 1 day) within 1 day.
2.3 criterion of therapeutical effect
Formulate with reference to " new Chinese medicine guideline of clinical investigations ".Curing: after treatment, integration recovers to 0 point, stomachache and other transference cures, stopping 3 cycles for the treatment of do not recur；Effective: less than 1/2 before symptom integral is down to treatment after treatment, stomachache substantially alleviates, and remaining symptom takes a turn for the better, and refuses to obey that analgesic also can adhere to work；Effective: 1/2～less than 3/4 before symptom integral is down to treatment after treatment, stomachache alleviates, and remaining symptom takes a turn for the better, and takes analgesic and can adhere to work；Invalid: stomachache and other symptoms are without substantially changing.Total effective rate=(curing number+effective number+significant figure)/total number of persons.
2.4 statistical procedures
Statistical method uses spss19.0 to carry out statistical analysis, uses t inspection, and P < 0.05 has statistical significance for difference.
3 therapeutic outcomes
Result of the test is such asFollowing table。
Table 2Four groups of patient clinical comparitive study after treatment
| Group | Number of cases | Cure (%) | Effective (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
| Treatment group | 31 | 21(67.7) | 5(16.1) | 3(9.7) | 2(6.5) | 29(93.5) |
| Compare one group | 23 | 5(21.7)* | 7(30.4) | 6(26.1) | 5(21.7) | 18(78.3)* |
| Compare two groups | 23 | 6(26.1)* | 8(34.8) | 4(17.4) | 5(21.7) | 18(78.3)* |
| Compare three groups | 23 | 6(26.1)* | 13(56.5) | 2(8.7) | 2(8.7) | 21(91.3) |
Note: * represents and compares with treatment group, P < 0.05.
FromTable 2Result it will be seen that after the treatment of 2 menstrual cycle, treatment group cures 21 people, effective 5 people, effective 3 people, invalid 2 people, and cure rate is 67.7%, and total effective rate is 93.5%.Treatment group with compare one group, compare two groups and compare, treatment group cure rate and total effective rate are all significantly better than comparison one group, compare two groups (P < 0.05), and difference has statistical significance.Treatment group compares with compareing three groups, and treatment group cure rate is significantly better than three groups (P < 0.05) of comparison, and difference has statistical significance.The above results shows that treatment group curative effect is better than matched group.
Embodiment 34 present invention is for the clinical experiment of the traditional Chinese medicine composition for treating menoxenia of traditional Chinese medical science moxibustion
1 clinical data
Select 110 example menoxenia patients as object of study, all through gynecologial examination and vaginal secretions routine examination, meet the diagnostic criteria of menoxenia in " guideline of clinical investigations of new Chinese medicine ".Exclusion standard: genitals's matter sexually transmitted disease (STD)s such as (1) adenomyosis, hysteromyoma, pituitary tumor become the menoxenia caused；(2) cardiovascular, Liver and kidney function serious hindrance person；(3) dysnoesia or psychiatric system class Disease；(4) allergic constitution or multi-medicament allergy sufferers, patient shows as preceeded menorrhea, delayed menstrual cycle, menstruation is the most irregular, menstrual blood volume is too little or too much.All patients are randomly divided into four groups, and often group patient's physical data (including age, the course of disease, the state of an illness) is through statistical analysis, no significant difference (P > 0.05), has comparability.
2 research methoies
2.1 Therapeutic Method
Treatment group: the method with reference to embodiment 16 and embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Within the 5th day after menstrual cycle, starting treatment, every day 1 time, continuous 10 times was 1 course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
Compare one group: Chinese medicine composition is as follows: Radix Angelicae Sinensis 45 parts, 40 parts of Flos Carthami, Radix Salviae Miltiorrhizae 50 parts, the Radix Aucklandiae 25 parts, Herba Leonuri 80 parts, Rhizoma Chuanxiong 35 parts, Borneolum Syntheticum 2.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Within the 5th day after menstrual cycle, starting treatment, every day 1 time, continuous 10 times was 1 course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
Compare two groups: Chinese medicine composition is as follows: Radix Angelicae Sinensis 45 parts, 40 parts of Flos Carthami, Radix Salviae Miltiorrhizae 50 parts, the Radix Aucklandiae 25 parts, Rhizoma Cyperi 40 parts, Rhizoma Chuanxiong 35 parts, Borneolum Syntheticum 2.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Within the 5th day after menstrual cycle, starting treatment, every day 1 time, continuous 10 times was 1 course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
Compare three groups: Chinese medicine composition is as follows: Radix Angelicae Sinensis 20 parts, 70 parts of Flos Carthami, Radix Salviae Miltiorrhizae 70 parts, the Radix Aucklandiae 60 parts, Rhizoma Cyperi 70 parts, Herba Leonuri 50 parts, Rhizoma Chuanxiong 70 parts, Borneolum Syntheticum 2.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Within the 5th day after menstrual cycle, starting treatment, every day 1 time, continuous 10 times was 1 course for the treatment of, altogether 2 courses for the treatment of of moxibustion.
2.2 symptom score standards
Before and after treatment, patient is carried out symptom score.Standards of grading: mark according to " guideline of clinical investigations of new Chinese medicine " Syndrome Scale quantization table, including symptoms such as lumbosacral aching pain, lower abdominal distention pain, distending pain of the breast, spiritlessness and weakness, deficiency of QI with disinclination to talk, aversion to cold and cold limbss, the lighter is 1 point, and middle person is 2 points, and severe one is 3 points.
2.3 criterion of therapeutical effect
Recovery from illness: stop in patient vaginal hemorrhage 3-5 days after treatment, menstrual cycle, through amount, recover normal menstrual period, clinical symptoms disappears substantially, and integration reduces >=95%；Effective: after treatment, patient vaginal hemorrhage stopped in 5-7 days,<100mL, recovers within 7 days menstrual period menorrhagia person's minimizing before amount relatively treatment, and clinical symptoms substantially disappears or alleviates, and integration reduces>=70%；Effective: to stop in patient vaginal hemorrhage 7-10 days after treatment, menstrual cycle, menstrual period, make moderate progress before amount relatively treatment, integration reduces >=30%；Invalid: after treatment, patient vaginal hemorrhage more than 10 days stops, menstrual cycle, through amount, menstrual period, without improving, integration reduces < 30%.Total effective rate=(curing number+effective number+significant figure)/total number of persons.
2.4 statistical procedures
Statistical method uses spss19.0 to carry out statistical analysis, uses t inspection, and P < 0.05 has statistical significance for difference.
3 therapeutic outcomes
Result of the test is such asFollowing table。
Table 3Four groups of patient clinical comparitive study after treatment
| Group | Number of cases | Cure (%) | Effective (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
| Treatment group | 35 | 23(65.7) | 7(20.0) | 3(8.6) | 2(5.7) | 33(94.3) |
| Compare one group | 25 | 6(24.0)* | 8(32.0) | 6(24.0) | 5(20.0) | 20(80.0)* |
| Compare two groups | 25 | 7(28.0)* | 9(36.0) | 5(20.0) | 4(16.0) | 21(84.0)* |
| Compare three groups | 25 | 8(32.0)* | 13(56.5) | 2(8.0) | 2(8.0) | 23(92.0) |
Note: * represents and compares with treatment group, P < 0.05.
FromTable 3Result it will be seen that after 2 course of therapy, treatment group cures 23 people, effective 7 people, effective 3 people, invalid 2 people, and cure rate is 65.7%, and total effective rate is 94.3%.Treatment group with compare one group, compare two groups and compare, the cure rate for the treatment of group and total effective rate are all significantly better than comparison one group, compare two groups (P < 0.05), and difference has statistical significance.Treatment group compares with compareing three groups, and treatment group cure rate is significantly better than three groups (P < 0.05) of comparison, and difference has statistical significance.The above results shows that treatment group curative effect is better than matched group.
Embodiment 35 present invention is for the clinical experiment of the traditional Chinese medicine composition for treating chronic pelvic inflammatory disease of traditional Chinese medical science moxibustion
1 clinical data
1.1 physical data
Select 120 example outpatients of gynecologies, meet chronic pelvic inflammatory disease diagnostic criteria, according to table of random number, patient is divided into treatment group, compares one group, compare two groups, compare three groups.Four groups of patient's physical data (including age, the course of disease, the state of an illness), through statistical analysis, no significant difference (P > 0.05), have comparability.
1.2 diagnostic criteria
Western medicine diagnose standard: (1) has acute pelvic inflammatory disease history；(2) lower abdomen pendant rises, pain and lumbosacral aching pain, often aggravates before and after tired, sexual intercourse and menstruation；(3) vaginal discharge；(4) fundus of uterus tenderness and side, uterus or bilateral touch streak enclosed mass；(5) ultrasonic examination can be visited and abnormal echo or irregular dark space or uterus rectum is recessed hydrops；(6) disease such as pelvic congestion or broad ligament angular vein varicose except.
Standards of Chinese Medical Syndrome Differentiation: inferior belly gas pain or twinge, sore spot fixes, and waist sacrum goes up painful, profuse leukorrhea, and yellow skin taste is smelly.Secondary disease shows themselves in that spiritlessness and weakness, low thermal fluctuation, and uncomfortable in chest indigestion and loss of appetite, menorrhagia or companion's menostaxis, abdominal pain in menstruation increases the weight of, and yellow urine is hard and dry or half congealed and not well.Tongue arteries and veins mostly is red or kermesinus, and petechia or ecchymosis are seen in tongue limit.
1.3 inclusive criteria
(1) chronic pelvic inflammatory disease diagnostic criteria is met；
(2) age 19-50 year non-menopausal women；
(3) signed Informed Consent Form.
1.4 exclusion standard
(1) age is at under-18s, more than 51 years old person；
(2) person that belongs to endometriosis；
(3) heart, liver, kidney and the serious disease patient such as hemopoietic system, psychotic are merged；
(4) to drug allergy person.
2 research methoies
2.1 Therapeutic Method
Treatment group: the method with reference to embodiment 16 and embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Starting treatment after clean period, every day 1 time, menstrual period stop moxibustion, continuously 2 months evaluation curative effects for the treatment of.
Compare one group: Chinese medicine composition is as follows: Radix Angelicae Sinensis 45 parts, 40 parts of Flos Carthami, Radix Salviae Miltiorrhizae 50 parts, the Radix Aucklandiae 25 parts, Herba Leonuri 80 parts, Rhizoma Chuanxiong 35 parts, Borneolum Syntheticum 2.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Starting treatment after clean period, every day 1 time, menstrual period stop moxibustion, continuously 2 months evaluation curative effects for the treatment of.
Compare two groups: Chinese medicine composition is as follows: Radix Angelicae Sinensis 45 parts, 40 parts of Flos Carthami, Radix Salviae Miltiorrhizae 50 parts, the Radix Aucklandiae 25 parts, Rhizoma Cyperi 40 parts, Rhizoma Chuanxiong 35 parts, Borneolum Syntheticum 2.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Starting treatment after clean period, every day 1 time, menstrual period stop moxibustion, continuously 2 months evaluation curative effects for the treatment of.
Compare three groups: Chinese medicine composition is as follows: Radix Angelicae Sinensis 20 parts, 70 parts of Flos Carthami, Radix Salviae Miltiorrhizae 70 parts, the Radix Aucklandiae 60 parts, Rhizoma Cyperi 70 parts, Herba Leonuri 50 parts, Rhizoma Chuanxiong 70 parts, Borneolum Syntheticum 2.Method with reference to embodiment 30 prepares Chinese medicines salt, with reference to the method moxibustion of embodiment 31.Starting treatment after clean period, every day 1 time, menstrual period stop moxibustion, continuously 2 months evaluation curative effects for the treatment of.
2.2 criterion of therapeutical effect
Curing: clinical symptoms, sign disappear, gynecological and ultrasonic examination report show no obvious abnormalities；
Effective: clinical symptoms, sign and gynecological and ultrasonic all have alleviate；
Invalid: clinical symptoms, sign and gynecological and ultrasonic examination are all not improved.
3 therapeutic outcomes
Result of the test is such asFollowing table。
Table 4Four groups of patient clinical comparitive study after treatment
| Group | Number of cases | Cure (%) | Effectively (%) | Invalid (%) | Total effective rate (%) |
| Treatment group | 30 | 23(76.7) | 3(10.0) | 4(13.3) | 26(86.7) |
| Compare one group | 30 | 9(30.0)* | 14(46.7) | 7(23.3) | 23(76.7)* |
| Compare two groups | 30 | 9(30.0)* | 13(43.3) | 8(26.7) | 22(73.3)* |
| Compare three groups | 30 | 12(40)* | 13(43.3) | 5(10.0) | 25(83.3) |
Note: * represents and compares with treatment group, P < 0.05.
FromTable 3Result it will be seen that through 2 months treat after, treatment group cures 23 people, effective 3 people, invalid 4 people, and cure rate is 76.7%, and total effective rate is 76.7.Treatment group with compare one group, compare two groups and compare, the cure rate for the treatment of group and total effective rate are all significantly better than comparison one group, compare two groups (P < 0.05), and difference has statistical significance.Treatment group compares with compareing three groups, and treatment group cure rate is significantly better than three groups (P < 0.05) of comparison, and difference has statistical significance.The above results shows that treatment group curative effect is better than matched group.
The above is only the preferred embodiment of the present invention; it should be pointed out that, for those skilled in the art, on the premise of without departing from the inventive method; can also make some improvement and supplement, these improve and supplement and also should be regarded as protection scope of the present invention.
Claims (9)
1. the Chinese medicine composition for traditional Chinese medical science moxibustion, it is characterised in that described Chinese medicine composition is by following heavy
The crude drug of amount part is made: Caulis Piperis Kadsurae 40-60 part, Radix Clematidis 30-50 part, Rhizoma Cibotii 35-55 part, Fructus Psoraleae
40-60 part, Herba speranskiae tuberculatae 50-70 part, Herba Lycopodii 30-50 part, Rhizoma Chuanxiong 25-45 part, Ramulus Mori 50-70 part, cattle
Knee joint 40-60 part, Borneolum Syntheticum 1-3 part.
The most according to claim 1 for the Chinese medicine composition of traditional Chinese medical science moxibustion, it is characterised in that described Chinese medicine
Compositions is made up of the crude drug of following weight portion: Caulis Piperis Kadsurae 45-55 part, Radix Clematidis 35-45 part, Rhizoma Cibotii 40-50
Part, Fructus Psoraleae 45-55 part, Herba speranskiae tuberculatae 55-65 part, Herba Lycopodii 35-45 part, Rhizoma Chuanxiong 30-40 part, Ramulus Mori
55-65 part, Radix Achyranthis Bidentatae 45-55 part, Borneolum Syntheticum 1-2 part.
The most according to claim 1 for the Chinese medicine composition of traditional Chinese medical science moxibustion, it is characterised in that described Chinese medicine
Compositions is made up of the crude drug of following weight portion: Caulis Piperis Kadsurae 50 parts, Radix Clematidis 40 parts, Rhizoma Cibotii 45 parts,
Fructus Psoraleae 50 parts, Herba speranskiae tuberculatae 60 parts, Herba Lycopodii 40 parts, Rhizoma Chuanxiong 35 parts, Ramulus Mori 60 parts, Radix Achyranthis Bidentatae 50
Part, Borneolum Syntheticum 2 parts.
The most according to claim 1 for the Chinese medicine composition of traditional Chinese medical science moxibustion, it is characterised in that in described
Drug composition is made up of the crude drug of following weight portion: Caulis Piperis Kadsurae 40 parts, Radix Clematidis 30 parts, Rhizoma Cibotii 35 parts,
Fructus Psoraleae 40 parts, Herba speranskiae tuberculatae 50 parts, Herba Lycopodii 30 parts, Rhizoma Chuanxiong 25 parts, Ramulus Mori 50 parts, Radix Achyranthis Bidentatae 40
Part, Borneolum Syntheticum 1 part.
5. according to the Chinese medicine composition being used for traditional Chinese medical science moxibustion described in claim 1, it is characterised in that described Chinese medicine
Compositions is made up of the crude drug of following weight portion: Caulis Piperis Kadsurae 60 parts, Radix Clematidis 50 parts, Rhizoma Cibotii 55 parts,
Fructus Psoraleae 60 parts, Herba speranskiae tuberculatae 70 parts, Herba Lycopodii 50 parts, Rhizoma Chuanxiong 45 parts, Ramulus Mori 70 parts, Radix Achyranthis Bidentatae 60
Part, Borneolum Syntheticum 3 parts.
6. the Chinese medicines salt for traditional Chinese medical science moxibustion, it is characterised in that described Chinese medicines salt include sea salt and
The Chinese medicine composition of the arbitrary described weight portion of claim 1-5.
Chinese medicines salt the most according to claim 6, it is characterised in that the weight portion of described sea salt is
700-900 part.
8. the arbitrary described Chinese medicine composition of claim 1-5, the arbitrary described Chinese medicines salt of claim 6-7
Application in the medicine of lumbar muscle strain, dysmenorrhea, menoxenia, pelvic inflammatory disease is treated in preparation.
Application the most according to claim 8, it is characterised in that the preparation method of described medicine is as follows:
(1) raw material is weighed according to proportioning；
(2) Chinese medicine composition is pulverized, cross 100 mesh sieves, obtain medicated powder；
(3) take sea salt slow fire parch, during light yellow complexion, add the medicated powder of step 2 preparation, parch together.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610494727.9A CN105943644B (en) | 2016-06-29 | 2016-06-29 | A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610494727.9A CN105943644B (en) | 2016-06-29 | 2016-06-29 | A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105943644A true CN105943644A (en) | 2016-09-21 |
| CN105943644B CN105943644B (en) | 2019-11-22 |
Family
ID=56902966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610494727.9A Active CN105943644B (en) | 2016-06-29 | 2016-06-29 | A kind of Chinese medicine moxibustion composition and its preparation method and application for lumbar muscle strain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105943644B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111617181A (en) * | 2020-06-04 | 2020-09-04 | 雷霞 | Medicine for treating rheumatic lumbocrural pain and traumatic injury |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015641A (en) * | 2007-02-16 | 2007-08-15 | 王卫平 | Moxibustion medicine for treating pain of lumbus, leg, neck and shoulder |
| CN102430011A (en) * | 2011-12-12 | 2012-05-02 | 上海市针灸经络研究所 | Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof |
| CN103860667A (en) * | 2014-02-28 | 2014-06-18 | 青岛恒波仪器有限公司 | Traditional Chinese medicine composition for treating lumbar muscle strain and preparation method thereof |
-
2016
- 2016-06-29 CN CN201610494727.9A patent/CN105943644B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015641A (en) * | 2007-02-16 | 2007-08-15 | 王卫平 | Moxibustion medicine for treating pain of lumbus, leg, neck and shoulder |
| CN102430011A (en) * | 2011-12-12 | 2012-05-02 | 上海市针灸经络研究所 | Traditional Chinese medicinal composition for traditional Chinese moxibustion treatment, preparation method and applications thereof |
| CN103860667A (en) * | 2014-02-28 | 2014-06-18 | 青岛恒波仪器有限公司 | Traditional Chinese medicine composition for treating lumbar muscle strain and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 叶佩青: "隔药饼灸结合刮痧治疗肾虚型腰肌劳损的临床研究", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111617181A (en) * | 2020-06-04 | 2020-09-04 | 雷霞 | Medicine for treating rheumatic lumbocrural pain and traumatic injury |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105943644B (en) | 2019-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101670076A (en) | Traditional Chinese medicine composition for treating disease of chronic nephritis and preparation method thereof | |
| CN102935211B (en) | Medicine for treating undesirable involution of uterus after childbirth or abortion | |
| CN105435297A (en) | Traditional Chinese medicine sanitary article for treating women dysmenorrheal, cold in uterus and vaginal eczema | |
| CN104491295A (en) | Traditional Chinese medicine composition used for treating polycystic ovarian syndrome | |
| CN104784673B (en) | A kind of Chinese traditional medicine navel for infantile diarrhea pastes | |
| CN103585378A (en) | A Chinese medicinal composition for treating female infertility, and its preparation method | |
| CN106620623A (en) | Hot-dressing external traditional Chinese medicinal composition and five-element moxibustion therapy packet containing composition | |
| CN102579897A (en) | Medicine for treating postoperative uroschesis of anorectal diseases and preparation method thereof | |
| CN101428106B (en) | Medicament composition for treating female infertility, and uses thereof | |
| CN103495055A (en) | Traditional Chinese medicine decoction for treating female endocrine disorders and preparation method thereof | |
| CN104435519A (en) | Pharmaceutical composition for treating primary dysmenorrhea | |
| CN112022916A (en) | Traditional Chinese medicine composition and preparation for treating postpartum body pain and preparation method and application thereof | |
| CN103720851A (en) | Traditional Chinese medicinal decoction for treating osteoproliferation | |
| CN103495126A (en) | Traditional Chinese medicine composition treating rheumatism | |
| CN101129736A (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN105943644A (en) | Traditional Chinese medicine moxibustion composition for lumbar muscle degeneration and preparation method and application of traditional Chinese medicine moxibustion composition | |
| CN106389557B (en) | A kind of Chinese medicine composition and its preparation method and application for Chinese medicine moxibustion | |
| CN103520450A (en) | Traditional Chinese medicine treating postpartum rheumatism | |
| CN102600333A (en) | Chinese medicinal composition for treating ovulatory dysfunction infertility by umbilical moxibustion | |
| CN106139015A (en) | A kind of Chinese medicine composition treating neck-shoulder pain, lumbago and leg pain | |
| CN102218119B (en) | Chinese herbal medicine for treating rheumatism, femoral head necrosis and puerperal fever | |
| CN105362987A (en) | Traditional Chinese medicine preparation for postpartum care | |
| CN101791348A (en) | Traditional Chinese medicine preparation for treatment of deficiency of five viscera | |
| CN109091570A (en) | A kind of Chinese medicine for treating chorionitis | |
| CN103127350B (en) | Medicine composition for Yang deficiency and blood stasis type gynecological diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |